These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
216 related items for PubMed ID: 11691783
1. Up-regulation of the ectodermal-neural cortex 1 (ENC1) gene, a downstream target of the beta-catenin/T-cell factor complex, in colorectal carcinomas. Fujita M, Furukawa Y, Tsunoda T, Tanaka T, Ogawa M, Nakamura Y. Cancer Res; 2001 Nov 01; 61(21):7722-6. PubMed ID: 11691783 [Abstract] [Full Text] [Related]
6. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y. Nat Genet; 2000 Mar 01; 24(3):245-50. PubMed ID: 10700176 [Abstract] [Full Text] [Related]
7. Identification of SP5 as a downstream gene of the beta-catenin/Tcf pathway and its enhanced expression in human colon cancer. Takahashi M, Nakamura Y, Obama K, Furukawa Y. Int J Oncol; 2005 Dec 01; 27(6):1483-7. PubMed ID: 16273202 [Abstract] [Full Text] [Related]
10. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Tetsu O, McCormick F. Nature; 1999 Apr 01; 398(6726):422-6. PubMed ID: 10201372 [Abstract] [Full Text] [Related]
11. The Wnt antagonist DICKKOPF-1 gene is a downstream target of beta-catenin/TCF and is downregulated in human colon cancer. González-Sancho JM, Aguilera O, García JM, Pendás-Franco N, Peña C, Cal S, García de Herreros A, Bonilla F, Muñoz A. Oncogene; 2005 Feb 03; 24(6):1098-103. PubMed ID: 15592505 [Abstract] [Full Text] [Related]
12. Regulation of cyclooxygenase-2 expression by the Wnt and ras pathways. Araki Y, Okamura S, Hussain SP, Nagashima M, He P, Shiseki M, Miura K, Harris CC. Cancer Res; 2003 Feb 01; 63(3):728-34. PubMed ID: 12566320 [Abstract] [Full Text] [Related]
13. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival. Alves-Guerra MC, Ronchini C, Capobianco AJ. Cancer Res; 2007 Sep 15; 67(18):8690-8. PubMed ID: 17875709 [Abstract] [Full Text] [Related]
14. Selective targeting to the hyperactive beta-catenin/T-cell factor pathway in colon cancer cells. Chen RH, McCormick F. Cancer Res; 2001 Jun 01; 61(11):4445-9. PubMed ID: 11389074 [Abstract] [Full Text] [Related]
15. Quercetin inhibit human SW480 colon cancer growth in association with inhibition of cyclin D1 and survivin expression through Wnt/beta-catenin signaling pathway. Shan BE, Wang MX, Li RQ. Cancer Invest; 2009 Jul 01; 27(6):604-12. PubMed ID: 19440933 [Abstract] [Full Text] [Related]
16. Overexpression of Icat induces G(2) arrest and cell death in tumor cell mutants for adenomatous polyposis coli, beta-catenin, or Axin. Sekiya T, Nakamura T, Kazuki Y, Oshimura M, Kohu K, Tago K, Ohwada S, Akiyama T. Cancer Res; 2002 Jun 01; 62(11):3322-6. PubMed ID: 12036951 [Abstract] [Full Text] [Related]
17. Identification of membrane-type matrix metalloproteinase-1 as a target of the beta-catenin/Tcf4 complex in human colorectal cancers. Takahashi M, Tsunoda T, Seiki M, Nakamura Y, Furukawa Y. Oncogene; 2002 Aug 29; 21(38):5861-7. PubMed ID: 12185585 [Abstract] [Full Text] [Related]
18. Butyrate-induced apoptotic cascade in colonic carcinoma cells: modulation of the beta-catenin-Tcf pathway and concordance with effects of sulindac and trichostatin A but not curcumin. Bordonaro M, Mariadason JM, Aslam F, Heerdt BG, Augenlicht LH. Cell Growth Differ; 1999 Oct 29; 10(10):713-20. PubMed ID: 10547075 [Abstract] [Full Text] [Related]
19. Novel colon cancer cell lines leading to better understanding of the diversity of respective primary cancers. Vécsey-Semjén B, Becker KF, Sinski A, Blennow E, Vietor I, Zatloukal K, Beug H, Wagner E, Huber LA. Oncogene; 2002 Jul 11; 21(30):4646-62. PubMed ID: 12096341 [Abstract] [Full Text] [Related]
20. Transactivation of vimentin by beta-catenin in human breast cancer cells. Gilles C, Polette M, Mestdagt M, Nawrocki-Raby B, Ruggeri P, Birembaut P, Foidart JM. Cancer Res; 2003 May 15; 63(10):2658-64. PubMed ID: 12750294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]